Loading...
Header Logo
Keywords
Last Name
Institution

Mayra Tisminetzky

Concepts (111)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Myocardial Infarction
11
2017
713
3.350
Why?
Acute Coronary Syndrome
3
2017
172
1.670
Why?
Hospitalization
7
2017
641
1.390
Why?
Electrocardiography
2
2015
286
1.260
Why?
Angiotensin-Converting Enzyme Inhibitors
3
2017
115
1.020
Why?
Hospital Mortality
6
2015
525
1.020
Why?
Patient Readmission
3
2015
153
0.950
Why?
Survivors
1
2017
81
0.820
Why?
Adrenergic beta-Antagonists
2
2017
125
0.820
Why?
Cognitive Therapy
2
2012
84
0.670
Why?
Myocardial Revascularization
1
2014
63
0.660
Why?
Secondary Prevention
1
2014
96
0.640
Why?
Diabetes Mellitus
2
2015
396
0.640
Why?
Forecasting
1
2014
163
0.640
Why?
Diabetes Complications
1
2014
96
0.630
Why?
Primary Prevention
1
2014
95
0.620
Why?
Treatment Outcome
8
2017
2568
0.600
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
145
0.590
Why?
Platelet Aggregation Inhibitors
1
2014
223
0.570
Why?
Length of Stay
5
2017
396
0.560
Why?
Massachusetts
9
2015
1516
0.540
Why?
Time Factors
7
2017
2561
0.540
Why?
Anxiety
1
2012
145
0.530
Why?
Middle Aged
12
2017
9685
0.520
Why?
Anxiety Disorders
1
2011
69
0.520
Why?
Retrospective Studies
7
2017
2422
0.510
Why?
Male
17
2017
16901
0.500
Why?
Aged
12
2017
7459
0.490
Why?
Female
17
2017
18323
0.480
Why?
Depressive Disorder, Major
1
2011
137
0.480
Why?
Patient Discharge
4
2017
204
0.440
Why?
Risk Factors
7
2017
2899
0.420
Why?
Depression
1
2012
385
0.420
Why?
Heart Failure
4
2017
426
0.410
Why?
Follow-Up Studies
4
2015
1529
0.410
Why?
Age Factors
4
2015
1090
0.390
Why?
Multivariate Analysis
3
2017
706
0.370
Why?
Aged, 80 and over
7
2017
2808
0.370
Why?
Humans
17
2017
33418
0.350
Why?
Survival Rate
3
2015
497
0.350
Why?
Prognosis
4
2015
890
0.350
Why?
Cohort Studies
4
2017
1346
0.330
Why?
Coronary Artery Bypass
2
2015
247
0.300
Why?
Sex Factors
3
2015
645
0.290
Why?
Chi-Square Distribution
3
2017
338
0.280
Why?
Adaptation, Psychological
2
2012
157
0.250
Why?
Disease-Free Survival
1
2017
125
0.210
Why?
Renal Insufficiency, Chronic
1
2017
41
0.210
Why?
Lung Diseases
1
2017
86
0.200
Why?
Diuretics
1
2015
31
0.190
Why?
Risk Assessment
3
2015
1037
0.180
Why?
Calcium Channel Blockers
1
2015
68
0.180
Why?
Longitudinal Studies
1
2017
692
0.180
Why?
Health Status
1
2017
312
0.180
Why?
Stroke Volume
1
2015
183
0.170
Why?
Quality of Life
1
2017
438
0.170
Why?
Academic Medical Centers
1
2015
170
0.160
Why?
Adult
4
2017
9416
0.160
Why?
Personality Inventory
2
2011
53
0.150
Why?
Aspirin
1
2014
158
0.150
Why?
Predictive Value of Tests
1
2015
653
0.150
Why?
Comorbidity
2
2015
706
0.150
Why?
Cooperative Behavior
1
2013
138
0.150
Why?
Case-Control Studies
1
2014
637
0.140
Why?
Models, Psychological
1
2012
94
0.140
Why?
Incidence
1
2014
755
0.140
Why?
Severity of Illness Index
1
2015
816
0.140
Why?
Pediatrics
1
2013
169
0.140
Why?
Psychiatric Status Rating Scales
1
2012
309
0.130
Why?
Fear
1
2011
31
0.130
Why?
Mental Health Services
1
2013
178
0.130
Why?
Angina, Unstable
1
2011
68
0.130
Why?
Health Services Accessibility
1
2013
277
0.130
Why?
Body Mass Index
1
2014
714
0.130
Why?
Outcome and Process Assessment (Health Care)
1
2010
179
0.110
Why?
Inpatients
1
2010
141
0.110
Why?
United States
1
2017
3862
0.110
Why?
Cross-Sectional Studies
1
2011
1190
0.100
Why?
Monoamine Oxidase Inhibitors
1
2002
9
0.080
Why?
Antidepressive Agents, Tricyclic
1
2002
16
0.080
Why?
Fluoxetine
1
2002
38
0.080
Why?
Odds Ratio
2
2015
582
0.080
Why?
Acute Disease
2
2015
518
0.070
Why?
Antidepressive Agents
1
2002
139
0.070
Why?
Depressive Disorder
1
2002
190
0.070
Why?
Logistic Models
2
2015
844
0.060
Why?
Cardiotonic Agents
1
2015
34
0.050
Why?
Urban Health
1
2015
42
0.050
Why?
Shock, Cardiogenic
1
2015
44
0.050
Why?
Chronic Disease
1
2017
537
0.040
Why?
Checklist
1
2013
25
0.040
Why?
Geriatric Assessment
1
2013
82
0.040
Why?
Confidence Intervals
1
2013
238
0.040
Why?
Survival Analysis
1
2013
394
0.040
Why?
Proportional Hazards Models
1
2013
451
0.040
Why?
Analysis of Variance
1
2013
544
0.040
Why?
Guideline Adherence
1
2013
219
0.030
Why?
Edema
1
2010
27
0.030
Why?
Mass Screening
1
2013
284
0.030
Why?
Chest Pain
1
2010
32
0.030
Why?
Practice Guidelines as Topic
1
2013
438
0.030
Why?
Dyspnea
1
2010
44
0.030
Why?
Adolescent
2
2013
3959
0.030
Why?
Health Care Surveys
1
2010
236
0.030
Why?
Cough
1
2010
120
0.030
Why?
Prospective Studies
1
2013
1587
0.030
Why?
Child
1
2013
2598
0.020
Why?
Double-Blind Method
1
2002
467
0.020
Why?
Postmenopause
1
2002
224
0.020
Why?
Randomized Controlled Trials as Topic
1
2002
319
0.020
Why?
Dose-Response Relationship, Drug
1
2002
718
0.020
Why?
Tisminetzky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_